QualifyHQ Logo

EndLess

Enalees is a biotech specialized in the development and marketing of lyophilized molecular diagnostic tests for animal healthcare in Europe. Leader of PCR type veterinary tests, Enalees uses the technology named LAMP (Loop-mediated isothermal amplification) to diagnose infectious canine, feline, and equine diseases in a simple, rapid, and reliable fashion. Thanks to its expertise in lyophilization, Enalees also provides development opportunities for other companies in the health, agriculture, and environment sector. Relocating the creation and production of rapid molecular diagnostic tests in France has also become an ambition of the company. Enalees already demonstrated the proof of concept by developing a Covid-19 screening test with several French companies thanks to its technical expertise in rapid molecular diagnosis. Its production capacity has augmented significantly, offering the possibility of assay development and product lyophilization for partners.

Founded

2016

Revenue

$1.0M - $2.5M

Funding

$16.8M

View similar companies

Qualify this Company in

minutes

While other tools waste time, we help you qualify better-fit companies in minutes, so your pipeline stays healthy, your team stays productive, and your deals move faster.

Start free trial

Start 7-Day Free Trial